Dickkopf1 (Dkk1) Alleviates Vascular Calcification by Regulating the Degradation of Phospholipase D1 (PLD1)

J Cardiovasc Transl Res. 2022 Dec;15(6):1327-1339. doi: 10.1007/s12265-022-10251-y. Epub 2022 Apr 14.

Abstract

Vascular calcification (VC) is a significant risk factor for cardiovascular mortality and morbidity in patients with atherosclerosis (AS), chronic kidney disease, and diabetes. Dickkopf1 (Dkk1) is a multifunctional secreted glycoprotein that has been explored as a novel potential antitumor target. Recently, Dkk1 was shown to be closely associated with AS development. However, the role of Dkk1 in VC remains elusive. In this study, we explored the role and molecular mechanisms of Dkk1 in VC based on a smooth muscle-specific Dkk1-knockout (Dkk1SMKO) mouse model. Our data indicated that Dkk1 expression was decreased under calcifying conditions and that Dkk1 overexpression alleviated high phosphate-induced vascular calcification. In vivo, smooth muscle Dkk1-specific knockout aggravated vascular calcification in mice. However, phospholipase D1 (PLD1) overexpression partially weakened the protective effect of Dkk1 against vascular calcification. Mechanistically, Dkk1 slowed vascular calcification by promoting the degradation of PLD1 via the regulating autophagosome formation and maturation. In conclusion, we found that Dkk1 could alleviate vascular calcification by regulating the degradation of PLD1.

Keywords: Dickkopf1; Phospholipase D1; Vascular calcification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Intercellular Signaling Peptides and Proteins* / genetics
  • Mice
  • Mice, Knockout
  • Myocytes, Smooth Muscle / pathology
  • Phospholipase D* / metabolism
  • Renal Insufficiency, Chronic*
  • Vascular Calcification* / genetics
  • Vascular Calcification* / prevention & control

Substances

  • Phospholipase D
  • phospholipase D1
  • Dkk1 protein, mouse
  • Intercellular Signaling Peptides and Proteins